Clinical trial
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent…
NCT00218049 · National Institute on Drug Abuse (NIDA), NIH · Terminated
Key facts
| NCT number | NCT00218049 |
|---|---|
| Title | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals |
| Official title | Phase 1, Double-blind, Placebo-controlled Assessment of Interactions Between 2 Doses of Cocaine and Three Doses of Escalating Vanoxerine (GBR 12909) in Cocaine Using Volunteers |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Texas |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine Abuse, Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | GBR 12909 |
| Enrollment | 3 |
| Start date | Dec 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: